IFRX – InflaRx N.V.

IFRX — Price & Forward EBITDA

Forward EBITDA (M)

Float Short %

3.79

Margin Of Safety %

Put/Call OI Ratio

0.03

EPS Next Q Diff

0.05

EPS Last/This Y

0.14

EPS This/Next Y

Price

0.97

Target Price

8.86

Analyst Recom

1.62

Performance Q

-15.16

Upside

N/A

Beta

1.55

Ticker: IFRX

19 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-03-09	IFRX	0.951	0.07	0.25	3054
2026-03-10	IFRX	0.943	0.07	0.00	3057
2026-03-11	IFRX	0.9666	0.04	0.00	5162
2026-03-12	IFRX	0.9824	0.04	16.00	5197
2026-03-13	IFRX	0.9809	0.04	17.67	5197
2026-03-17	IFRX	0.9187	0.05	0.01	5486
2026-03-18	IFRX	0.8745	0.05	0.00	5663
2026-03-19	IFRX	0.9169	0.04	0.00	6147
2026-03-20	IFRX	0.9432	0.04	0.00	6151
2026-03-23	IFRX	0.9744	0.04	0.00	3811
2026-03-24	IFRX	1.02	0.04	2.14	3863
2026-03-25	IFRX	0.9496	0.05	0.00	3908
2026-03-26	IFRX	0.93	0.04	0.00	4924
2026-03-27	IFRX	0.926	0.03	11.00	6312
2026-03-30	IFRX	0.8332	0.03	0.00	6322
2026-03-31	IFRX	0.8904	0.03	0.33	6322
2026-04-01	IFRX	0.8881	0.03	0.00	6328
2026-04-02	IFRX	0.9175	0.03	0.00	6360
2026-04-06	IFRX	0.9477	0.03	999.99	6363
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

19 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-03-09	IFRX	0.95	-82.5	-8.2	-0.67
2026-03-10	IFRX	0.94	-82.5	-14.1	-0.67
2026-03-11	IFRX	0.97	-82.5	-38.6	-0.67
2026-03-12	IFRX	0.98	-82.5	-25.4	-0.67
2026-03-13	IFRX	0.95	-82.5	-11.5	-0.67
2026-03-17	IFRX	0.93	-82.5	-21.0	-0.67
2026-03-18	IFRX	0.88	-82.5	-2.1	-0.67
2026-03-19	IFRX	0.92	-82.5	-34.1	-0.67
2026-03-20	IFRX	0.95	-82.5	-30.9	-0.67
2026-03-23	IFRX	0.98	-82.5	-11.8	-0.67
2026-03-24	IFRX	1.01	-82.5	-11.8	-0.67
2026-03-25	IFRX	0.95	-82.5	16.3	-0.67
2026-03-26	IFRX	0.92	-82.5	-10.3	-0.67
2026-03-27	IFRX	0.92	-82.5	-20.1	-0.67
2026-03-30	IFRX	0.83	-13.5	27.9	-0.65
2026-03-31	IFRX	0.88	-13.5	-13.6	-0.65
2026-04-01	IFRX	0.89	-13.5	5.2	-0.65
2026-04-02	IFRX	0.92	-13.5	-2.9	-0.65
2026-04-06	IFRX	0.94	-13.5	-3.8	-0.65
2026-04-07	IFRX	0.97	-13.5	-4.3	-0.65
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-03-09	IFRX	0.00	-1.28	4.45
2026-03-10	IFRX	0.00	-1.28	4.45
2026-03-11	IFRX	0.00	-1.28	4.25
2026-03-12	IFRX	0.00	-1.28	4.25
2026-03-13	IFRX	0.00	-1.28	4.25
2026-03-17	IFRX	0.00	-1.23	4.25
2026-03-18	IFRX	0.00	-1.23	4.25
2026-03-19	IFRX	0.00	-1.23	4.25
2026-03-20	IFRX	0.00	-1.23	4.25
2026-03-23	IFRX	0.00	-1.23	4.25
2026-03-24	IFRX	0.00	-1.23	4.25
2026-03-25	IFRX	0.00	-1.23	3.79
2026-03-26	IFRX	0.00	-1.23	3.79
2026-03-27	IFRX	0.00	-1.23	3.79
2026-03-30	IFRX	0.00	-1.15	3.79
2026-03-31	IFRX	0.00	-1.15	3.79
2026-04-01	IFRX	0.00	-1.15	3.79
2026-04-02	IFRX	0.00	-1.15	3.79
2026-04-06	IFRX	0.00	-1.15	3.79
2026-04-07	IFRX	0.00	-1.15	3.79
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.17

Avg. EPS Est. Current Quarter

-0.15

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

Institutional Transactions

-1.15

Beta

1.55

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

86.6

Max Drawdown 5-Year %

-88

Target Price

8.86

P/E

Forward P/E

PEG

P/S

P/B

1.23

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y

-0.65

EPS Next Y. (Est.)

-0.64

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

2.78

Return on Equity vs Sector %

-137.3

Return on Equity vs Industry %

-120.7

EPS 1 7Days Diff

EPS 1 30Days Diff

0.04

EBIT Estimation

-4.3

◆ IFRX Healthcare

$0.97

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

6/25

Volume

0/15

Valuation

12/20

TP/AR

3/10

Options

0/10

RSI

55.2

Range 1M

65.1%

Sup Dist

8.7%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

7/25

Growth

12/30

Estimates

2/20

Inst/Vol

3/15

Options

0/10

EPS Yr

12.7%

EPS NY

-9.7%

52W%

21.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +813.4% upside

Quality

2/30

Valuation

16/30

Growth

10/25

Stability

6/10

LT Trend

2/5

Upside

+813.4%

Quality

InflaRx N.V.

Sector: Healthcare

Industry: Biotechnology

Employees: 65

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States. The company's C5a is an inflammatory mediator to treat variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a a first-in-class monoclonal anti-human complement factor C5a antibody, which is in Phase 3 clinical trial for the treatment for patients suffering from early septic organ dysfunction, biological proof of concept was established, demonstrating its unique C5a blocking ability and selectivity; Izicopan, an oral, low molecular weight drug to target C5aR with high affinity and selectivity has completed completing Phase 2a trials; and IFX002, an advancement of vilobelimab technology, which is in preclinical development for the treatment of chronic inflammatory indications. It has co-development agreement with Staidson (Beijing) BioPharmaceuticals Co., Ltd.; Cell line sales agreement with Catalent Pharma Solutions LLC; Clinical Trial Collaboration Agreement with the U.S. DHHSs, Administration for Strategic Preparedness and Response (ASPR), BARDA and PPD Development, L.P., or PPD. InflaRx N.V. was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. The company was founded in 2007 and is headquartered in Jena, Germany.

IFRX

Latest News

—

Caricamento notizie per IFRX…

stock quote shares IFRX – InflaRx N.V. Stock Price stock today

news today IFRX – InflaRx N.V. stock forecast ,stock prediction 2023 2024 2025

marketwatch IFRX – InflaRx N.V. yahoo finance google finance

stock history IFRX – InflaRx N.V. invest stock market

stock prices IFRX premarket after hours

ticker IFRX fair value insiders trading

IFRX – InflaRx N.V.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: IFRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y